4-hour Live MOUD Training - 8/9/2025-Presentation Slides - 4-hour Live MOUD Training with Dr. Wyatt-

Presentation Slides - 4-hour Live MOUD Training with Dr. Wyatt-

Pdf Summary

This document is an extensive training resource designed for healthcare professionals on Medications for Opioid Use Disorders (MOUD), presented by Dr. Stephen A. Wyatt. The training, supported by the Providers Clinical Support System (PCSS-MOUD) and funded by SAMHSA, aims to improve knowledge and clinical skills in treating opioid use disorder (OUD) through evidence-based treatments.<br /><br />It begins with an overview of addiction as a chronic brain disease involving genetic, neurobiological, environmental, and behavioral factors. The public health impact of substance use disorders (SUDs) is underscored, noting high mortality rates from opioids, tobacco, and alcohol, with increasing opioid overdose deaths despite effective treatments. The training stresses the importance of early identification, proper screening, and addressing stigma and attitudes to improve care.<br /><br />Detailed pharmacology of MOUD is covered, focusing on methadone (a full mu-opioid agonist), buprenorphine (a partial agonist), and naltrexone (an antagonist). Buprenorphine’s safety profile, dosing strategies, formulations (including combination with naloxone to reduce misuse), and challenges such as initiating treatment in fentanyl users are explained. The training highlights the evidence that MOUD improves retention, reduces overdose deaths, and enhances patient outcomes, while acknowledging barriers like provider training gaps and insurance issues.<br /><br />Patient evaluation guidance emphasizes building non-judgmental therapeutic alliances, comprehensive assessment of medical, psychiatric, social, and substance use history, and using validated screening tools. Special populations discussed include pregnant women (with methadone and buprenorphine use and neonatal withdrawal management), adolescents (with specific MOUD approvals), and patients with comorbid mental illness or chronic medical conditions.<br /><br />Clinical application sections address initiation, stabilization, maintenance, and tapering of buprenorphine, handling precipitated withdrawal, and use of naltrexone. Practical considerations for pain management during MOUD treatment and perioperative care are included. The document concludes with case studies and resources for mentoring and professional support.<br /><br />Overall, this training offers comprehensive, evidence-based guidance on effective initiation and management of MOUD, aiming to empower healthcare providers to address the opioid crisis through improved treatment access and quality care.

Keywords

Medications for Opioid Use Disorders

MOUD

Opioid Use Disorder

Addiction as Brain Disease

Methadone

Buprenorphine

Naltrexone

Substance Use Disorders

Clinical Training for Healthcare Professionals

Opioid Overdose Prevention